FindTrial
Sign In

Study of the safety and efficacy of dexmedetomidine in the analgesia of epidural delivery of ropivacaine

Study of the safety and efficacy of dexmedetomidine in the analgesia of epidural delivery of ropivacaine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014849
Enrollment
Unknown
Registered
2018-02-09
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childbirth pain

Interventions

Dexmedetomidine group:Dexmedetomidine
Ropivacaine group:Ropivacaine

Sponsors

Guangzhou Women and Children Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: After entering the delivery room requires painless childbirth (excluding painless childbirth contraindications)

Exclusion criteria

Exclusion criteria: No painless childbirth mothers

Design outcomes

Primary

MeasureTime frame
Pain score;—

Countries

China

Contacts

Public ContactXingrong Song

Guangzhou Women and Children Medical Center

songxingrong510623@163.com+86 13922416303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026